Gallentes, Adrian Jade A.
HRN: 23-76-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2023
AMPICILLIN 250MG (VIAL)
10/18/2023
10/25/2023
IV
175mg
Q12
Omphalitis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes